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Quality of Life 
Sir, 
As a surgeon who tries to treat claudicants holisticallj6 
I was interested to read the paper by Currie et al. (Eur 
] Vasc Endovasc Surg, 10: 356-361) addressing the 
impact of claudication on quality of life. I do, however 
have some reservations as to their methods and their 
conclusion that mild claudicants hould be treated by 
early resort to angioplasty: 
1. The study was not randomised, so it is difficult to 
draw any firm conclusions. 
2. After their initial consultation, patients treated by 
unsupervised exercise were not seen again until 
their quality of life assessment a 3 months, whereas 
those undergoing surgical or radiol~gical inter- 
vention would have had numerous doctor/hospital 
interactions. Claudicants taking placebos in drug 
trials invariably walk further at the end of the trial 
and minimalist supervised exercise programs can 
produce dramatic increases in walking distance. 1 It 
is likely therefore that such interactions have a huge 
positive effect on walking distance and therefore 
quality of life ("something is being done"). In 
addition, no mention is made of advice/support to
stop smoking, lowering lipids etc. which are a vital 
part of conservative management. 
3. My main criticism concerns the timing of the second 
quality of life assessment at 3 months. In their 
randomised trial of supervised exercise versus 
angioplast~ Creasy et al. 2 found that at 3 months 
angioplasty produced an increase in walking dis- 
tance but this was quickly followed by a decline to 
pre-intervention levels. Conversely, supervised 
exercise had little effect at 3 months, but at 6 months 
and thereafter, there was a significant improvement 
in walking that was far superior to angioplasty. 
Walking distance is directly related to quality of life 
measured by the SF36 questionnaire, 3 so it is unfair 
of Currie et al. to expect unsupervised exercise to act 
more rapidly than an intensive supervised program. 
Had they repeated their assessment at, sa)~ 12 
months they would probably have obtained a 
completely opposite answer and so arrived at an 
entirely different conclusion. 
4. Finally, the suggestion that fears of potential sys- 
temic effects of claudication-induced ischaemia sup- 
port the argument for angioplasty is unjustified. 
Such effects are, at present, merely interesting 
biochemical observations and should not influence 
clinical decisions. In any case, we do not yet know 
the effect of either angioplasty or supervised exer- 
cise programs on these observations. 
Improved quality (and quantity) of life for most 
claudicants will surely be achieved by better, more 
complete and structured conservative management 
protocols (the "tortoise") rather than by the short term 
benefits of an expensive radiological hare. 
N.C. Hickey 
Worcester, U.K~. 
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Authors Reply 
We thank Mr Hickey for his interest in our paper, and 
acknowledge his comments on the shortcomings of 
non-randomised studies. We did not give a detailed 
account of best medical treatment because our 1980 
study of exercise training 1 included smoking and 
dietary advice. 
We disagree with the assertion that timing the 
second quality of life assessment at 3 months was 
inappropriate. We are concerned by the absence of 
evidence to support the claim that contradictory 
results would have been obtained if the quality of life 
assessments had been repeated at a year. The study by 
Creasy et al. 2 has yet to be confirmed and did not 
include formal assessments of quality of life. On the 
contrary; Whyman et al. 3 recently showed that claudi- 
cants treated by angioplasty walked further and had 
better quality of life scores at 6 months than those 
randomised to an exercise programme. 
Mr Hickey's polemic concludes by favouring con- 
servative management, whereas the results of our 
study are supportive of intervention. However, we 
concur in recognising the importance of quality of life 
and hope that future studies will include this measure- 
ment of outcome. 
I.C. Currie, Y.G. Wilson, R.N. Baird and 
P.M. Lamont 
Bristol, U.K. 
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